Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 23 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-4.50 Insider Own1.45% Shs Outstand4.52M Perf Week-6.86%
Market Cap6.98M Forward P/E- EPS next Y-2.39 Insider Trans56.98% Shs Float4.21M Perf Month-12.83%
Income-13.32M PEG- EPS next Q-1.09 Inst Own3.28% Short Float1.11% Perf Quarter-25.23%
Sales4.91M P/S1.42 EPS this Y43.16% Inst Trans-6.50% Short Ratio1.52 Perf Half Y41.74%
Book/sh-0.30 P/B- EPS next Y0.69% ROA-75.54% Short Interest0.05M Perf Year-58.84%
Cash/sh2.00 P/C0.82 EPS next 5Y- ROE-522.50% 52W Range0.97 - 5.09 Perf YTD-6.86%
Dividend Est.- P/FCF- EPS past 5Y68.20% ROI- 52W High-67.98% Beta0.56
Dividend TTM- Quick Ratio0.92 Sales past 5Y406.45% Gross Margin84.84% 52W Low68.15% ATR (14)0.13
Dividend Ex-Date- Current Ratio0.92 EPS Y/Y TTM61.88% Oper. Margin-271.14% RSI (14)36.24 Volatility8.21% 6.98%
Employees20 Debt/Eq- Sales Y/Y TTM2093.30% Profit Margin-271.04% Recom1.00 Target Price19.33
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q66.65% Payout- Rel Volume0.56 Prev Close1.66
Sales Surprise-10.60% EPS Surprise48.72% Sales Q/Q769.54% EarningsMar 05 AMC Avg Volume30.76K Price1.63
SMA20-10.36% SMA50-12.24% SMA200-13.51% Trades Volume17,176 Change-1.81%
Date Action Analyst Rating Change Price Target Change
Jan-25-21Initiated Ladenburg Thalmann Buy $8
Oct-16-20Initiated Maxim Group Buy $6
Apr-22-24 09:00AM
Apr-09-24 07:00AM
Mar-27-24 08:00AM
Mar-25-24 08:00AM
07:00AM Loading…
Mar-11-24 07:00AM
Mar-07-24 08:59AM
Mar-06-24 01:43PM
Mar-05-24 09:52PM
Feb-27-24 08:00AM
Dec-18-23 07:00AM
Dec-12-23 08:00AM
Nov-29-23 08:00AM
07:00AM Loading…
Nov-20-23 07:00AM
Nov-15-23 07:00AM
Nov-13-23 09:31AM
Nov-03-23 07:00AM
Nov-01-23 09:29AM
Oct-31-23 04:10PM
Oct-25-23 09:21AM
Oct-23-23 04:05PM
Oct-10-23 07:00AM
Oct-09-23 07:00AM
Sep-19-23 01:07PM
Sep-15-23 11:17AM
Sep-11-23 12:44PM
12:49PM Loading…
Sep-08-23 12:49PM
Sep-05-23 01:13PM
Aug-30-23 07:00AM
Aug-18-23 09:55AM
Aug-15-23 10:58AM
Aug-14-23 04:05PM
Aug-11-23 06:28PM
Aug-08-23 04:05PM
Aug-03-23 07:00AM
Jul-27-23 05:34PM
Jul-13-23 07:00AM
Jun-29-23 07:00AM
Jun-14-23 07:00AM
Jun-08-23 07:00AM
Jun-01-23 07:00AM
May-30-23 07:00AM
May-25-23 07:00AM
May-16-23 07:00AM
May-12-23 07:00AM
May-02-23 07:00AM
Apr-28-23 12:55PM
Apr-21-23 09:01AM
Apr-20-23 05:25PM
Apr-19-23 07:00AM
Apr-18-23 04:15PM
Apr-12-23 07:00AM
Mar-28-23 07:00AM
Mar-22-23 07:00AM
Feb-23-23 05:35PM
Feb-14-23 07:00AM
Feb-01-23 07:00AM
Jan-18-23 07:00AM
Jan-05-23 04:15PM
Nov-21-22 06:53AM
Nov-19-22 08:24AM
Nov-02-22 07:00AM
Oct-26-22 07:00AM
Oct-20-22 04:05PM
Oct-19-22 07:00AM
Oct-18-22 07:00AM
Oct-06-22 07:00AM
Oct-05-22 07:00AM
Oct-04-22 07:15AM
Sep-22-22 08:35AM
Sep-12-22 07:00AM
Sep-08-22 07:00AM
Sep-06-22 07:00AM
Aug-29-22 07:00AM
Aug-23-22 07:00AM
Aug-22-22 09:13AM
Aug-17-22 05:46PM
Aug-15-22 08:37AM
Aug-13-22 01:06PM
Jul-28-22 07:00AM
Jul-27-22 07:00AM
Jul-21-22 04:05PM
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HEDRICK MARC HChief Executive OfficerNov 20 '23Sale1.962,0684,053170Dec 15 05:09 PM
Lenk Robert PDirectorNov 16 '23Buy1.951,0001,95025,160Nov 17 07:00 AM
Lenk Robert PDirectorNov 15 '23Buy1.771,0001,77024,160Nov 17 07:00 AM
Lenk Robert PDirectorNov 13 '23Buy1.434,0005,72023,160Nov 15 07:00 AM
Lenk Robert PDirectorNov 10 '23Buy1.452,0002,90019,160Nov 15 07:00 AM
Lenk Robert PDirectorNov 09 '23Buy1.594,1996,67617,160Nov 13 07:00 AM
Lenk Robert PDirectorNov 08 '23Buy1.655,0008,25012,961Nov 13 07:00 AM
Lenk Robert PDirectorNov 07 '23Buy1.646,0009,8407,961Nov 08 07:00 AM
Lenk Robert PDirectorNov 06 '23Buy1.501,3952,0921,961Nov 08 07:00 AM
Clowes HowardDirectorSep 13 '23Buy1.436,99310,02211,693Sep 15 07:00 AM
Petersen GregDirectorSep 11 '23Buy1.7020,00034,06224,166Sep 12 07:00 AM
Clowes HowardDirectorJun 06 '23Buy3.981,0003,9804,700Jun 08 07:00 AM
Clowes HowardDirectorMay 03 '23Buy3.642,5009,1023,700May 04 07:00 AM